Several inhibitory mediators, such as VEGFA, TGFB1, and FOXP3, were significantly upregulated in EA SCLC patients, but some antigen presentation genes, such as MICA, MICB, and TAP1, were significantly downregulated in the EA cohort. This evidence concerns the gene FOXP3 and Esophageal atresia.